In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells

Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases

(2020) Yuehong Chen et al.   Journal of Immunology Research

Quantitative Control of Gene-Engineered T-Cell Activity through the Covalent Attachment of Targeting Ligands to a Universal Immune Receptor

(2020) Nicholas G. Minutolo et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

The Emergence of Universal Immune Receptor T Cell Therapy for Cancer

(2019) Nicholas G. Minutolo et al.   Frontiers in Oncology

Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus

(2019) Rita Kansal et al.   Science Translational Medicine

On the mark: genetically engineered immunotherapies for autoimmunity

(2019) Christoph T Ellebrecht et al.   CURRENT OPINION IN IMMUNOLOGY

B cell targeted therapies in autoimmune disease

(2019) Jennifer L Barnas et al.   CURRENT OPINION IN IMMUNOLOGY

Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses

(2018) Jang Hwan Cho et al.   CELL

Targeting B Cells and Plasma Cells in Autoimmune Diseases

(2018) Katharina Hofmann et al.   Frontiers in Immunology

Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?

(2017) Michael J. E. Marshall et al.   Frontiers in Immunology

Versatile strategy for controlling the specificity and activity of engineered T cells

(2016) Jennifer S. Y. Ma et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies

(2016) David T. Rodgers et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease

(2016) C. T. Ellebrecht et al.   SCIENCE

Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis

(2015) Anja Schwenzer et al.   ANNALS OF THE RHEUMATIC DISEASES

Redirection of Genetically Engineered CAR-T Cells Using Bifunctional Small Molecules

(2015) Min Soo Kim et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Anti-citrullinated peptides as autoantigens in rheumatoid arthritis—relevance to treatment

(2014) Lazaros I. Sakkas et al.   AUTOIMMUNITY REVIEWS

The fibrin-derived citrullinated peptide β60–74Cit60,72,74bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies

(2013) M Cornillet et al.   ANNALS OF THE RHEUMATIC DISEASES

Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritis

(2013) Parawee Suwannalai et al.   ANNALS OF THE RHEUMATIC DISEASES

Presence and Role of Anti-Citrullinated Protein Antibodies in Experimental Arthritis Models

(2012) Tineke Cantaert et al.   ARTHRITIS AND RHEUMATISM

The antigen specificity of the rheumatoid arthritis-associated ACPA directed to citrullinated fibrin is very closely restricted

(2011) Cristina Iobagiu et al.   JOURNAL OF AUTOIMMUNITY

Anti-CCP antibodies: the past, the present and the future

(2011) Walther J. van Venrooij et al.   Nature Reviews Rheumatology

Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens

(2010) P. Suwannalai et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry

(2010) J.-E. Gottenberg et al.   ARTHRITIS AND RHEUMATISM

Identification of antibody epitopes in the CB-11 peptide of bovine type II collagen recognized by sera from arthritis-susceptible and -resistant rhesus monkeys

(2010) S. TURNER et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial

(2009) Clifton O. Bingham et al.   ARTHRITIS AND RHEUMATISM

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

(2009) Sander van Assen et al.   ARTHRITIS AND RHEUMATISM